By A Mystery Man Writer
Epigenetic modifications are known to regulate cell phenotype during cancer progression, including breast cancer. Unlike genetic alterations, changes in the epigenome are reversible, thus potentially reversed by epi-drugs. Breast cancer, the most common cause of cancer death worldwide in women, encompasses multiple histopathological and molecular subtypes. Several lines of evidence demonstrated distortion of the epigenetic landscape in breast cancer. Interestingly, mammary cells isolated from breast cancer patients and cultured ex vivo maintained the tumorigenic phenotype and exhibited aberrant epigenetic modifications. Recent studies indicated that the therapeutic efficiency for breast cancer regimens has increased over time, resulting in reduced mortality. Future medical treatment for breast cancer patients, however, will likely depend upon a better understanding of epigenetic modifications. The present review aims to outline different epigenetic mechanisms including DNA methylation, histone modifications, and ncRNAs with their impact on breast cancer, as well as to discuss studies highlighting the central role of epigenetic mechanisms in breast cancer pathogenesis. We propose new research areas that may facilitate locus-specific epigenome editing as breast cancer therapeutics.
pub.mdpi-res.com/ijms/ijms-13-01497/article_deploy
IJMS, Free Full-Text, onoo 2 no2
IJMS, Free Full-Text, onoo 2 no2
IJMS, Free Full-Text, onoo 2 no2
IJMS, Free Full-Text
IJMS, Free Full-Text, Wet Strength Tissue Paper
Ijms Free Full Text Characterization And Scaled Up Production Of
pub.mdpi-res.com/img/journals/ijms-logo-social.png
IJMS, Free Full-Text, scp 7143 j
Ijms Free Full Text Assessment Of Bones Deficient In Fibrillin 0
IJMS, Free Full-Text
IJMS, Free Full-Text
IJMS, Free Full-Text, Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease, HTML